BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  How to Become a Top Performer When You Didn’t Get Enough Training

  If you aren’t properly trained it can be very difficult to achieve successful results. Here’s how to become a top performer, even when you didn’t get enough training.

  February 26, 2019

   · 

  3 min read

   · 

  Porschia Parker-Griffin
• 

  Job Trends

  Amicus Therapeutics to Hire 200 Researchers at New Gene Therapy Center in Philadelphia

  Amicus Therapeutics, headquartered in Cranbury, New Jersey, announced it is launching a Global Research and Gene Therapy Center of Excellence in Philadelphia.

  February 26, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Pharm Country

  Oyster Point Pharma Scores $93 Million Series B to Focus Its Gaze on Dry Eye Disease

  The company’s two lead product candidates are OC-01 and OC-02, which are delivered by way of an ocular surface-sparing nasal spray that stimulates the trigeminal parasympathetic pathway to induce natural tear film production.

  February 26, 2019

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Lilly Named One of the World’s Most Ethical Companies

  Ethisphere announced its 13th Annual World’s Most Ethical Companies list and one biopharmaceutical company made it—Eli Lilly & Co.

  February 26, 2019

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Bacteriophages to the Rescue: A Possible Approach to Antibiotic Resistance

  Ella Balasa, a 26-year-old from Richmond, Virginia, recently made the news when she was apparently successfully treated for a lung infection using a kind of virus called a bacteriophage.

  February 26, 2019

   · 

  3 min read

   · 

  Mark Terry
• Drug Development

  Immunic Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of IMU-838, an Oral Therapy for Patients with Relapsing-Remitting Multiple Sclerosis

  Immunic AG announced enrollment of the first patient in a phase 2 clinical study of IMU-838 for the treatment of patients with relapsing-remitting multiple sclerosis.

  February 26, 2019

   · 

  8 min read
• 

  Business

  Top 5 Biotech Companies to Emerge From Bay Area Incubators

  The San Francisco Business Times recently looked at top alumni from Bay Area incubators. Some of those companies are now brand-name companies like Uber and Reddit. Here’s a look at the biotech companies on their list.

  February 26, 2019

   · 

  2 min read

   · 

  Mark Terry
• Business

  Retrophin Reports Fourth Quarter and Full Year 2018 Financial Results

  Two pivotal Phase 3 studies of sparsentan progressing on-track to enable potential first-in-class treatment for both FSGS and IgAN

  February 26, 2019

   · 

  18 min read
• 

  Business

  Amidst FDA Rejection, Immunomedics’ CEO and President Steps Down

  In addition to its fourth-quarter financial report, Morris Plains, NJ-based Immunomedics announced that its president, chief executive officer and board member, Michael Pehl, was stepping down for personal reasons.

  February 26, 2019

   · 

  2 min read

   · 

  Mark Terry
• Business

  Genovis Year-end Report January – December 2018

  Genovis has chosen to apply IFRS 16 in advance, as well as the simplification rule regarding short-term leases.

  February 26, 2019

   · 

  5 min read